Q3 2015 13F Holders as of 9/30/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
147M
-
Number of holders
-
913
-
Total 13F shares, excl. options
-
199M
-
Shares change
-
-11.1M
-
Total reported value, excl. options
-
$58.1B
-
Value change
-
-$3.92B
-
Put/Call ratio
-
1.62
-
Number of buys
-
489
-
Number of sells
-
-427
-
Price
-
$291.81
Significant Holders of BIOGEN INC. - Common Stock (BIIB) as of Q3 2015
1,113 filings reported holding BIIB - BIOGEN INC. - Common Stock as of Q3 2015.
BIOGEN INC. - Common Stock (BIIB) has 913 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 199M shares
.
Largest 10 shareholders include FMR LLC (16.6M shares), PRIMECAP MANAGEMENT CO/CA/ (15.8M shares), VANGUARD GROUP INC (13.6M shares), STATE STREET CORP (9.49M shares), Clearbridge Investments, LLC (8.58M shares), BlackRock Institutional Trust Company, N.A. (6.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.03M shares), WELLINGTON MANAGEMENT GROUP LLP (5.66M shares), BlackRock Fund Advisors (5.35M shares), and SANDS CAPITAL MANAGEMENT, LLC (4.12M shares).
This table shows the top 913 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.